Does the interval from melphalan administration to infusion of hematopoietic stem cells affect outcomes after autologous transplantation in multiple myeloma?

Hematology, Transfusion and Cell Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles